[ad_1]
Encompass Health (NYSE:EHC – Get Rating) will be issuing its quarterly earnings data after the market closes on Tuesday, February 7th. Analysts expect the company to announce earnings of $0.85 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Encompass Health Trading Down 0.7 %
EHC opened at $60.94 on Tuesday. Encompass Health has a one year low of $44.33 and a one year high of $74.61. The stock has a market capitalization of $6.08 billion, a PE ratio of 22.40, a P/E/G ratio of 2.59 and a beta of 1.02. The business’s 50 day moving average price is $59.11 and its 200 day moving average price is $53.81. The company has a debt-to-equity ratio of 1.59, a quick ratio of 1.21 and a current ratio of 1.21.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on EHC shares. TheStreet raised Encompass Health from a “c+” rating to a “b-” rating in a research report on Wednesday, December 21st. StockNews.com started coverage on Encompass Health in a research report on Wednesday, October 12th. They issued a “hold” rating on the stock. Stephens cut their target price on Encompass Health from $60.00 to $58.00 and set an “overweight” rating on the stock in a research report on Friday, October 28th. Finally, Raymond James boosted their target price on Encompass Health from $65.00 to $72.00 and gave the company a “strong-buy” rating in a research report on Friday, October 28th. One research analyst has rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $64.13.
Institutional Trading of Encompass Health
A number of large investors have recently modified their holdings of EHC. US Bancorp DE increased its holdings in Encompass Health by 66.4% in the first quarter. US Bancorp DE now owns 9,336 shares of the company’s stock valued at $664,000 after buying an additional 3,725 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new position in Encompass Health in the first quarter valued at $318,000. PNC Financial Services Group Inc. increased its holdings in Encompass Health by 10.5% in the first quarter. PNC Financial Services Group Inc. now owns 8,750 shares of the company’s stock valued at $622,000 after buying an additional 834 shares during the last quarter. Bank of Montreal Can increased its holdings in Encompass Health by 1.5% in the first quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock valued at $806,000 after buying an additional 173 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Encompass Health by 10.5% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 36,463 shares of the company’s stock valued at $2,593,000 after buying an additional 3,477 shares during the last quarter. Hedge funds and other institutional investors own 96.14% of the company’s stock.
About Encompass Health
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Encompass Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Encompass Health wasn’t on the list.
While Encompass Health currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
[ad_2]
Source link
